Skip Navigation


JAC Advance Access originally published online on November 20, 2007
Journal of Antimicrobial Chemotherapy 2008 61(2):286-290; doi:10.1093/jac/dkm452
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/2/286    most recent
dkm452v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Enríquez, R.
Right arrow Articles by Vázquez, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enríquez, R.
Right arrow Articles by Vázquez, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Fluoroquinolone resistance in Neisseria meningitidis in Spain

Rocío Enríquez, Raquel Abad, Celia Salcedo, Sonia Pérez and Julio A. Vázquez*

Reference Laboratory for Meningococci, Servicio de Bacteriología, National Centre for Microbiology, National Institute of Health Carlos III, Majadahonda, Madrid, Spain

Received 21 June 2007; returned 15 August 2007; revised 29 October 2007; accepted 29 October 2007

* Corresponding author. Tel: +34-91-8223617; Fax: +34-91-5097919; E-mail: jvazquez{at}isciii.es

Objectives: To assess the ciprofloxacin resistance of Neisseria meningitidis isolated from 1999 through 2006 in Spain, susceptibility testing was conducted on 5300 isolates.

Methods: Ten isolates showed MICs of ciprofloxacin ranging between 0.06 and 0.25 mg/L, and they were characterized by analysis for mutations within the quinolone resistance determining regions (QRDRs) in the gyrA, gyrB, parC and parE genes. Mutations in the mtrR gene were also analysed.

Results and conclusions: Single mutations in gyrA appeared to be the main mechanism involved,Thr-91->Ile being the most frequent substitution seen. Two meningococci had four different gyrAsubstitutions. No mutations in the QRDRs of the parC and gyrB genes were detected, and three strains showed a His-495->Asn substitution in the parE gene. In addition, two different alterations in the mtrR gene affecting the expression of the MtrCDE efflux system were identified which may also contribute to the reduced susceptibility to quinolones seen in three strains.

Keywords: ciprofloxacin , QRDRs , meningococci


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
R. Enriquez, R. Abad, C. Salcedo, and J. A. Vazquez
Nalidixic Acid Disk for Laboratory Detection of Ciprofloxacin Resistance in Neisseria meningitidis
Antimicrob. Agents Chemother., February 1, 2009; 53(2): 796 - 797.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.